Meibomian gland dysfunction: The past, present, and future

Eye and Contact Lens

Volumn 36, Issue 5, 2010, Pages 249-253

  Foulks, Gary N ^a,b   Borchman, Douglas ^a  

^a University of Louisville School of Medicine   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Lipid; Meibomian gland; Meibum

Indexed keywords

AZITHROMYCIN; CHOLESTEROL ESTER; CYCLOSPORIN; DIACYLGLYCEROL; DOXYCYCLINE; MINOCYCLINE; OMEGA 3 FATTY ACID; PHOSPHATIDYLCHOLINE; SATURATED FATTY ACID; STEROID; TETRACYCLINE; TRIACYLGLYCEROL;

AGE; BACTERIAL COLONIZATION; BLEPHARITIS; CHEMICAL ANALYSIS; CLINICAL EVALUATION; DRUG RESPONSE; DRY EYE; ENTHALPY; EYE BLOOD FLOW; EYE CARE; EYE DISCOMFORT; EYE INFLAMMATION; HUMAN; HYPERTHERMIC THERAPY; INFLAMMATION; INFRARED SPECTROSCOPY; KERATINIZATION; KERATOCONJUNCTIVITIS; LACRIMAL FLUID; MEIBOMIAN GLAND; MEIBOMIAN GLAND DYSFUNCTION; OPTOMETRY; PHASE TRANSITION; PREVALENCE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; REVIEW; SEBACEOUS GLAND DISEASE; SPECTROSCOPY; TEAR FILM; TEAR FLOW; VISUAL DISORDER;

ANIMALS; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; EYELID DISEASES; HISTORY, 17TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HISTORY, ANCIENT; HUMANS; MEIBOMIAN GLANDS; OPHTHALMOLOGY;

EID: 77957555438     PISSN: 15422321     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICL.0b013e3181ef0d37     Document Type: Review

References (59)

1. Duke Elder S., Wybar KC The Anatomy of the Visual System. London, Henry Kimptom, 1961, p 577.
2. Meibom H. De vasis palpebrarum novis epistolae. Helmstadi, 1666.
3. Foulks GN, Bron AJ Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf 2003; 1: 107-126.
4. Sullivan DA, Sullivan BD, Ullman M.D., et al. Androgen influence on the meibomian gland. Invest Ophthalmol Vis Sci 2000; 41: 3732-3742.
5. McCulley JP, Sciallis GF Meibomian keratoconjunctivitis. Am J Ophthalmol 1977; 84: 788-793.
6. Korb DR, Henriquez AS Meibomian gland dysfunction and contact lens intolerance. J Am Optom Assoc 1980; 51: 243-251.
7. Jester JV, Rife L, Nii D., et al. In vivo biomicroscopy and photography of meibomian glands in a rabbit model of meibomian gland dysfunction. Am J Ophthalmol 1982; 22: 660-667.
8. Lambert R, Smith RE Hyperkeratinization in a rabbit model of meibomian gland dysfunction. Am J Ophthalmol 1988; 105: 703-705.
9. Gutgesell VJ, Stern GA, Hood CI Histopathology of meibomian gland dysfunction. Am J Ophthalmol 1982; 94: 383-387.
10. Shine WE, McCulley JP The role of cholesterol in chronic blepharitis. Invest Ophthalmol Vis Sci 1991; 32: 2272-2280.
11. Shine WE, McCulley JP Role of wax ester fatty alcohols in chronic blepharitis. Invest Ophthalmol 1993; 34: 3515-3521.
12. Shine WE, McCulley JP Polar lipids in human meibomian secretions. Curr Eye Res 2003; 26: 89-94.
13. Dougherty JM, McCulley JP Analysis of the free fatty acid component of meibomian gland secretions in chronic blepharitis. Invest Ophthalmol Vis Sci 1986; 27: 52-56.
14. Dougherty JM, McCulley JP, Silvany R.E., et al. The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci. Invest Ophthalmol Vis Sci 1991; 32: 2970-2975.
15. Bron AJ, Tiffany JM The meibomian glands and tear film lipids: Structure, function, and control. Adv Exp Med Biol 1998; 438: 281-295.
16. Bron AJ, Tiffany JM, Gouveia S.M., et al. Functional aspects of the tear film lipid layer. Exp Eye Res 2004; 78: 347-360.
17. Bron AJ, Tiffany JM The contribution of meibomian gland disease to dry eye. Ocul Surf 2004; 2: 149-165.
18. McCulley JP, Dougherty JM, Deneau DG Classification of chronic blepharitis. Ophthalmology 1982; 89: 1173-1180.
19. Foulks GN. Blepharitis: Lid margin disease and the ocular surface. In: Holland EJ, Mannis MJ, eds. Ocular Surface Disease. New York, Springer, 2001.
20. Lemp M, Nichols K. Blepharitis in the United States 2009: A survey-based perspective on prevalence and treatment. Ocul Surf 2009; 7(2 SUPPL.): S1-S14.
21. Hom MM, Martinson JR, Knapp L.L., et al. Prevalence of meibomian gland dysfunction. Optom Vis Sci 1991; 68: 390-391.
22. Ong BL, Larke JR Meibomian gland dysfunction: Some clinical, biochemical and physical observations. Ophthalmic Physiol Opt 1990; 10: 144-148.
23. Butovich IA, Uchiyama E, McCulley JP Lipids of human meibum: Massspectrometric analysis and structural elucidation. J Lipid Res 2007; 48: 2220-2235.
24. Mathers WD, Lane JA, Zimmerman MB Tear film changes associated with normal aging. Cornea 1996; 15: 229-234.
25. Mathers WD, Lane JA Meibomian gland lipids, evaporation, and tear film stability. Adv Exp Med Biol 1998; 438: 349-360.
26. Cho P, Yap M. Age, gender, and tear break-up time. Optom Vis Sci 1993; 70: 828-831.
27. Arita R, Itoh K, Inoue K., et al. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology 2008; 115: 911-915.
28. Norn M. Expressibility of meibomian secretion. Relation to age, lipid precorneal film, scales, foam, hair and pigmentation. Acta Ophthalmol (Copenh) 1987; 65: 137-142.
29. Den S, Shimizu K, Ikeda T., et al. Association between meibomian gland changes and aging, sex, or tear function. Cornea 2006; 25: 651-655.
30. Hykin PG, Bron AJ Age-related morphological changes in lid margin and meibomian gland anatomy. Cornea 1992; 11: 334-342.
31. Obata H. Anatomy and histopathology of human meibomian gland. Cornea 2002; 21(7 SUPPL.): S70-S74.
32. Chew CK, Hykin PG, Jansweijer C, et al. The casual level of meibomian lipids in humans. Curr Eye Res 1993; 12: 255-259.
33. Sullivan BD, Evans JE, Dana M.R., et al. Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions. Arch Ophthalmol 2006; 124: 1286-1292.
34. Kaercher T, Möbius D. Stability and flexibility of the lipid layer of the tear film and their pathologic changes in a biophysical experiment. Fortschr Ophthalmol 1989; 86: 245-248.
35. Borchman D, Foulks GN, Yappert M.C., et al. Temperature-induced conformational changes in human tear lipids hydrocarbon chains. Biopolymers 2007; 87: 124-133.
36. Borchman D, Foulks GN, Yappert M.C., et al. Human meibum lipid hydrocarbon chain conformational and thermodynamic changes with age. Ophthalmic Res 2010; 44: 34-42.
37. Foulks GN, Borchman D, Yappert M.C., et al. Topical azithromycin therapy of meibomian gland dysfunction: Clinical response and lipid alterations. Cornea 2010; 29: 781-788.
38. Malinowski EH, Howery DG Factor analysis in chemistry. New York, John Wiley and Sons, 1980.
39. Malinowski EH. Theory of the distribution of error eigenvalues resulting from principal component analysis with applications to spectroscopic. J Chemom 1987; 1: 33-44.
40. Sutter JM, Kalivas JH, Lang PM Which principal component to utilize for principal component regression. J Chemom 1992; 6: 217-225.
41. Shlens, J. A Tutorial on Principal Component Analysis. 2005. Available at: http://www.snl.salk.edu/~shlens/pub/notes/pca.pdf. Accessed February 5, 2010.
42. Hemmila A, McGill J, Ritter D. Fourier transform infrared reflectance spectra of latent fingerprints: A biometric gauge for the age of an individual. J Forensic Sci 2008; 53: 369-331.
43. Borchman D, Foulks GN, Yappert MC Confirmation of changes in human meibum lipid infrared spectra with age using principle component analysis. Curr Eye Res (in press).
44. Foulks GN. The correlation between the tear film lipid layer and dry eye disease. Surv Ophthalmol 2007; 52: 369-374.
45. Shine WE, McCulley JP Meibomian gland triglyceride fatty acid differences in chronic blepharitis patients. Cornea 1996; 15: 340-346.
46. Shine WE, McCulley JP Association of meibum oleic acid with meibomian seborrhea. Cornea 2000; 19: 72-74.
47. Joffre C, Souchier M, Leclere L., et al. Branched-chain fatty acids, increased in tears of blepharitis patients, are not toxic for conjunctival cells. Br J Ophthalmol 2009; 93: 1391-1395.
48. Shine WE, McCulley JP Keratoconjunctivitis sicca associated with meibomian secretion polar lipid abnormality. Arch Ophthalmol 1998; 116: 849-852.
49. Shine WE, McCulley JP Meibomianitis polar lipid abnormalities. Cornea 2004; 23: 781-783.
50. Butovich IA, Wojtowicz JC, Molai M. Human tear film and meibum. Very long chain wax esters and (O-acyl)-omega-hydroxy fatty acids of meibum. J Lipid Res 2009; 50: 2471-2485.
51. Butovich IA. Cholesteryl esters as a depot for very long chain fatty acids in human meibum. J Lipid Res 2009; 50: 501-513.
52. Butovich IA. On the lipid composition of human meibum and tears: Comparative analysis of nonpolar lipids. Invest Ophthalmol Vis Sci 2008; 49: 3779-3789.
53. Borchman D, Foulks GN, Yappert MC Changes in human meibum lipid with meibomian gland dysfunction using principal component analysis. Exp Eye Res (in press).
54. Oshima Y, Sato H, Zaghloul A., et al. Characterization of human meibum lipid using Raman spectroscopy. Curr Eye Res 2009; 34: 824-835.
55. Nagymihalyi A, Dikstein S, Tiffany JM The influence of eyelid temperature on the delivery of meibomian oil. Exp Eye Res 2004; 78: 367-370.
56. Paranjpe DR, Foulks GN Therapy of meibomian gland disease. Ophthalmol Clin North Am 2003; 16: 37-42.
57. Perry HD, Doshi-Carnevale S, Donnenfeld E.D., et al. Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction. Cornea 2006; 25: 171-175.
58. Rubin M, Rao SN Efficacy of topical cyclosporine 0.05% in the treatment of posterior blepharitis. J Ocul Pharmacol Ther 2006; 22: 47-53.
59. Macsai MS. The role of omega 3 dietary supplementation in the treatment of blepharitis and meibomian gland dysfunction. Trans Am Ophthalmol Soc 2008; 106: 336.